Friday, 25 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet

View original at globenewswire.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet Washington, D.C., April 04, 2026 (GLOBE NEWSWIRE) -- There is a specific kind of dread that comes from learning a threat was already present before any symptoms appea…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The collapse has already started behind the scenes

    60% confidence
  • In 2008, warned that financial catastrophe was imminent three weeks before Lehman Brothers collapsed

    60% confidence
  • The evidence of a coming AI market collapse is already present in the balance sheets, financing arrangements, insider behavior, and structural fragilities of the AI sector

    60% confidence
  • In January 2020, issued CONTAGION note predicting a pandemic-driven market panic three weeks before stocks suffered the fastest crash in history

    60% confidence
  • The CFO of the AI company identified as central failure point has implied publicly that a government bailout may be required

    60% confidence
  • This is not a prediction, it is an observation - describing what is already happening, visible to anyone with access to the right data points

    60% confidence
  • The company at the center of the AI financial system is showing the same distress signals Lehman showed weeks before its failure

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet — Source | Via News | ViaNews EU